Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells

Published:2017-03 Issue: Volume:389 Page:33-40
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Tuttle Traci R.,Takiar Vinita,Kumar Bhavna,Kumar Pawan,Ben-Jonathan Nira

Funder

NIH

DOD

Marlene Harris-Ride Cincinnati

Department of Radiation Oncology

Keith Casper, the Department of Otolaryngology

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference50 articles.

1. Pharmacoeconomic issues in head and neck oncology;de Souza;Curr. Opin. Oncol.,2013

2. Recent advances in head and neck cancer;Haddad;N. Engl. J. Med.,2008

3. State-of-the-art and emerging treatment options in the management of head and neck cancer: news from 2013;Denaro;Oncology,2014

4. Human papillomavirus in cervical and head-and-neck cancer;Psyrri;Nat. Clin. Pract. Oncol.,2008

5. Promising new molecular targeted therapies in head and neck cancer;Dorsey;Drugs,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolism-Related Prognostic Biomarkers, Purine Metabolism and Anti-Tumor Immunity in Colon Adenocarcinoma;Frontiers in Bioscience-Landmark;2023-12-01

2. NO-HDAC dual inhibitors;European Journal of Medicinal Chemistry;2022-01

3. An Analysis of the Multifaceted Roles of Heme in the Pathogenesis of Cancer and Related Diseases;Cancers;2021-08-17

4. Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics;Vaccines;2021-01-27

5. YC-1 potentiates the antitumor activity of gefitinib by inhibiting HIF-1α and promoting the endocytic trafficking and degradation of EGFR in gefitinib-resistant non-small-cell lung cancer cells;European Journal of Pharmacology;2020-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3